Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 (COVID-19) Spike 681P | 8G10B1 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Spike 681P | 8G10C8 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Spike S2 | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Spike S2 | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike P681H (Alpha, Mu Variant) | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike P26S (Gamma Variant) | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane Protein | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein | monoclonal | Mouse | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Glycoprotein | monoclonal | Chimeric Human/Mouse | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Glycoprotein | monoclonal | Chimeric Human/Mouse | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Glycoprotein | monoclonal | Mouse | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike NTD | monoclonal | Recombinant Human | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 004 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 004 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 08 | Mouse | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 08 | Mouse | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 019 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 019 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 1 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 10 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 12 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 13 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 16 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 3 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 8 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Non Structural Protein 9 | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ORF7a Protein | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ORF8 Protein | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD | monoclonal | Mouse | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Omicron B.1 | monoclonal | Recombinant Human | n/a | affinity purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) S1 Protein | monoclonal | Mouse | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) S1 Protein | polyclonal | Rabbit | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) S4 Protein | monoclonal | Mouse | n/a | affinity purified | 50 µg, 100 µg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Recombinant Rabbit | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Recombinant Rabbit | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Recombinant Rabbit | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Recombinant Rabbit | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Recombinant Rabbit | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Recombinant Rabbit | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Mouse | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Mouse | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid | monoclonal | Mouse | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (COVID-19) Nucleocapsid | [85E9] | Recombinant Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Nucleocapsid | 75G5a | Recombinant Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Nucleocapsid | 84C4a | Recombinant Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Nucleocapsid | 84D7 | Recombinant Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Nucleocapsid | 85B4 | Recombinant Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Nucleocapsid | 85C1 | Recombinant Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |